SCA
CELG

Sippican Capital Advisors’s Celgene Corp CELG Stock Holding History

Sippican Capital Advisors’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-4,967
Closed -$318K – 112
2018
Q4 		$318K Buy
+4,967
New +$367K 0.43% 72
2018
Q2 		– Sell
-5,706
Closed -$509K – 110
2018
Q1 		$509K Sell
5,706
-5,500
-49% -$528K 0.53% 60
2017
Q4 		$1.17M Buy
11,206
+5,068
+83% +$572K 1.14% 38
2017
Q3 		$895K Buy
6,138
+361
+6% +$49.2K 0.92% 45
2017
Q2 		$750K Buy
5,777
+1,264
+28% +$155K 0.81% 50
2017
Q1 		$562K Buy
4,513
+1,218
+37% +$146K 0.6% 59
2016
Q4 		$381K Buy
+3,295
New +$367K 0.4% 75

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Sippican Capital Advisors's CELG Position: Q1 2019 in Review

Sippican Capital Advisors sold out of Celgene Corp (CELG) in Q1 2019, closing a stake of 4,967 shares — an estimated $318K sold.

Sippican Capital Advisors first reported a position in CELG in Q4 2016 and held it in 7 quarters. The position peaked at $1.17M in Q4 2017. 1,389 funds tracked by Wall St. Rank hold CELG as of Q1 2019.

  • Sippican Capital Advisors reported no remaining Celgene Corp position as of Q1 2019 after selling out during the quarter.
  • Sippican Capital Advisors sold 4,967 Celgene Corp shares in Q1 2019, an estimated $318K.
  • Sippican Capital Advisors first reported a position in Celgene Corp in Q4 2016 and held it in 7 quarters.
  • Sippican Capital Advisors's Celgene Corp position peaked at $1.17M in Q4 2017.
  • 1,389 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2019.

Based on Sippican Capital Advisors's 13F filing for Q1 2019, filed 17 Apr 2019.